APA
Martín-Rodríguez P., Guerra B., Hueso-Falcón I., Aranda-Tavío H., Díaz-Chico J., Quintana J., Estévez F., Díaz-Chico B., Amesty A., Estévez-Braun A. & Fernández-Pérez L. (2018). A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. : Frontiers in pharmacology.
Chicago
Martín-Rodríguez Patricia, Guerra Borja, Hueso-Falcón Idaira, Aranda-Tavío Haidee, Díaz-Chico Juan, Quintana José, Estévez Francisco, Díaz-Chico Bonifacio, Amesty Angel, Estévez-Braun Ana and Fernández-Pérez Leandro. 2018. A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. : Frontiers in pharmacology.
Harvard
Martín-Rodríguez P., Guerra B., Hueso-Falcón I., Aranda-Tavío H., Díaz-Chico J., Quintana J., Estévez F., Díaz-Chico B., Amesty A., Estévez-Braun A. and Fernández-Pérez L. (2018). A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. : Frontiers in pharmacology.
MLA
Martín-Rodríguez Patricia, Guerra Borja, Hueso-Falcón Idaira, Aranda-Tavío Haidee, Díaz-Chico Juan, Quintana José, Estévez Francisco, Díaz-Chico Bonifacio, Amesty Angel, Estévez-Braun Ana and Fernández-Pérez Leandro. A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. : Frontiers in pharmacology. 2018.